About the authors
Абдрасулов Каныбек Дуйшобекович, аспирант кафедры онкологии и лучевой терапии Кыргызского государственного медицинского института переподготовки и повышения квалификации им. С.Б. Даниярова; врач онколог отделении опухолей кишечника Национального центра онкологии и гематологии при МЗ КР, Бишкек, Кыргызская Республика
Осомбаев Муратбек Шаршембиевич, кандидат медицинских наук, доцент, заведующий отделением опухолей кишечника, Национального центра онкологии и гематологии при МЗ КР, Бишкек, Кыргызская Республика
Джекшенов Марат Джумабекович, кандидат медицинских наук, врач онколог, научный сотрудник отделения опухолей кишечника Национального центра онкологии и гематологии, Бишкек, Кыргызская Республика
Тургунбаев Уланбек Айтбаевич, кандидат медицинских наук, врач онколог, старший научный сотрудник отделения химиотерапии Национального центра онкологии и гематологии, Бишкек, Кыргызская Республика
Мукамбетов Нурлан Касенович, врач онколог, научный сотрудник отделения опухолей кишечника Национального центра онкологии и гематологии, Бишкек, Кыргызская Республика
Самудинов Бекжан Турдубекович, врач онколог, научный сотрудник отделения опухолей кишечника Национального центра онкологии и гематологии, Бишкек, Кыргызская Республика
Abdrasulov Kanybek Duishobekovich, postgraduate student of the Department of Oncology and Radiation Therapy of the Kyrgyz State Medical Institute of Retraining and Advanced Training named after S.B. Daniyarov; oncologist of the Department of Intestinal Tumors of the National Center of Oncology and Hematology under the Ministry of Health of the Kyrgyz Republic, Bishkek, Kyrgyz Republic
Osombaev Muratbek Sharshembievich, Candidate of Medical Sciences, Associate Professor, Head of the Department of Intestinal Tumors, National Center for Oncology and Hematology, Ministry of Health of the Kyrgyz Republic, Bishkek, Kyrgyz Republic
Dzhekshenov Marat Dzhumabekovich, Candidate of Medical Sciences, oncologist, researcher, Department of Intestinal Tumors, National Center of Oncology and Hematology, Bishkek, Kyrgyz Republic
Turgunbaev Ulanbek Aitbaevich, Candidate of Medical Sciences, oncologist, senior researcher at the Chemotherapy Department of the National Center for Oncology and Hematology, Bishkek, Kyrgyz Republic
Mukambetov Nurlan Kasenovich, oncologist, researcher at the Department of Intestinal Tumors of the National Center for Oncology and Hematology, Bishkek, Kyrgyz Republic
Samudinov Bekzhan Turdubekovich, oncologist, researcher at the Department of Intestinal Tumors of the National Center for Oncology and Hematology, Bishkek, Kyrgyz Republic
Абдрасулов Каныбек Дүйшөбекович, С.Б. Данияров атындагы Кыргыз мамлекеттик кайра даярдоо жана квалификацияны жогорулатуу медициналык институтунун онкология жана радиациялык терапия кафедрасынын аспиранты; Кыргыз Республикасынын Саламаттык сактоо министрлигинин Улуттук онкология жана гематология борборунун жоон ичеги шишиктери бөлүмүнүн онкологу, Бишкек, Кыргыз Республикасы
Осомбаев Муратбек Шаршембиевич, медицина илимдеринин кандидаты, доцент, Кыргыз Республикасынын Саламаттык сактоо министрлигинин Улуттук онкология жана гематология борборунун жоон ичеги шишиктери бөлүмүнүн башчысы, Бишкек, Кыргыз Республикасы
Джекшенов Марат Жумабекович, медицина илимдеринин кандидаты, онколог, Улуттук онкология жана гематология борборунун жоон ичеги шишиктери бөлүмүнүн илимий кызматкери, Бишкек, Кыргыз Республикасы
Тургунбаев Уланбек Айтбаевич, медицина илимдеринин кандидаты, онколог, химиотерапия бөлүмүнүн улук илимий кызматкери, Улуттук онкология жана гематология борборунун Бишкек шаары, Кыргыз Республикасы
Мукамбетов Нурлан Касенович, онколог, илимий кызматкер, Улуттук онкология жана гематология борборунун жоон ичеги шишиктери бөлүмүнүн илимий кызматкери, Бишкек, Кыргыз Республикасы
Самудинов Бекжан Турдубекович, онколог, Улуттук онкология жана гематология борборунун ичеги шишиктери бөлүмүнүн илимий кызматкери, Бишкек, Кыргыз Республикасы
References
1. Сибирский онкологический журнал. – 2023. – Т. 22, № 2. – С. 160–167.
2. Диагностика и лечение колоректального рака [Электронный ресурс]: Клиническое руководство / Министерство здраво
охранения Кыргызской Республики; Национальный центр онкологии МЗ КР. – Режим доступа: https://ksmi.kg/images
/files/KR _%20Kolorektal_rak.pdf.
3. Hepatic Metastasis from Colorectal Cancer [Text] / A. I. Valderrama-Treviño, B. Barrera-Mera, J. C. Ceballos-Villalva [et al.] //
Euroasian J Hepatogastroenterol. – 2017. – Vol. 7, N 2. – P. 166–175.
4. The liver-first approach to the management of colorectal cancer with synchronous hepatic metastases: a systematic review [Text]
/ S. Jegatheeswaran, J. M. Mason, H. C. Hancock, A. K. Siriwardena // JAMA Surg. – 2013. – Vol. 148, N 4. – P. 385–391.
5. Стратегия и тактика комплексного лечения больных метастатическим колоректальным раком [Текст] / А. Б. Моисеенко,
А. В. Гуляев, А. М. Карачун [Текст] // Злокачественные опухоли. – 2015. – № 2. – С. 78–84.
6. Колоректальный рак с синхронными отдаленными метастазами: обоснование циторедуктивных операций и перспективы
– взгляд хирурга [Текст] / В.А. Алиев, Ю.А. Барсуков, А.В. Николаев [и др.] // Онкологическая колопроктология. – 2012.
– № 4. – С. 15–20.
7. A uniform residual tumor (R) classification: integration of the R classification and the circumferential margin status [Text] / C.
Wittekind, C. Compton, P. Quirke [et al.] // Cancer. – 2009. – Vol. 115, N 15. – P. 3483–3488.
8. Improved survival in metastatic colorectal cancer is associatedwith adoption of hepatic resection and improved chemotherapy
[Text] / S. Kopetz, J. G. Chang, M. J. Overman [et al.] // J Clin Oncol. – 2009. – Vol. 27, N 2. – P. 3677–3683.
9. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer [Text] / E. Van Cutsem, A. Cer
vantes, R. Adam [et al.] // Ann Oncol. – 2016. – Vol. 27, N 8. – P. 1386–1422.
10. EORTC liver metastases intergroup randomized phase III study 40983: long-term survival results [Text] / B. Nordlinger, H.
Sorbye, B. Glimelius [et al.] // J Clin Oncol. – 2012, vol. 30 (Suppl.). Abstr. 3508.
11. Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique
or biologic surrogate? / E. Sadot, B. G. Koerkamp, J. N. Leal [et al.] // Ann Surg. – 2015. – Vol. 262, N 3. – P. 476–485.
12. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases [Text] / Y. Fong, J. Fortner, R. L. Sun [et al.] // Ann Surg. – 1999. – Vol. 230, N 3. – P. 309–318.
13. Патютко, Ю. И. Гемигепатэктомия в лечении больных резектабельными метастазами колоректального рака в печени с
неблагоприятным прогнозом [Текст] / Ю. И. Патютко, А. Г. Котельников, К. Г. Мамонтов [и др.] // Вопросы онкологии.
‒ 2015. – Т. 61, № 3. – С. 439–447.
14. Скипенко, О. Г. Хирургическое лечение метастазов колоректального рака в печени [Текст] / О. Г. Скипенко, Л. О. Полищук
// Хирургия. Журнал им. Н. И. Пирогова. – 2009. – № 5. – С. 15–22.
15. Калинин, Е. В. Хирургический компонент лечения метастатического колоректального рака: современное состояние про
блемы [Текст] / Е. В. Калинин, Л. О. Петров // Онкология. Журнал им. П. А. Герцена. – 2016. – Т. 5, № 6. – С. 81–87.
16. Непосредственные результаты неоадъювантной химиотерапии у больных метастатическим колоректальным раком с
изолированным поражением печени [Текст] / А. Ю. Добродеев, Д. Н. Костромицкий, А. С. Тарасова [и др.] // Сибирский
онкологический журнал. – 2022. – Т. 21, № 6. – С. 17–24.
17. Early survival and safety of ALPPS: first report of the International ALPPS Registry [Text] / E. Schadde, V. Ardiles, R. Robles-
Campos [et al.] // Ann Surg. – 2014. – Vol. 260, N 5. – P. 829–836.
18. High mortality after ALPPS for perihilar cholangiocarcinoma: case-control analysis including the first series from the international
ALPPS registry [Text] / P. B. Olthof, R. J. Coelen, J. K. Wiggers [et al.] // HPB (Oxford) ‒ 2017. – Т. 19, № 5. – С. 381–387.
19. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged
extended right hepatic resection in small-for-size settings [Text] / A. A. Schnitzbauer, S. A. Lang, H. Goessmann [et al.] // Ann
Surg. ‒ 2012. – Vol. 255, N 3. – P. 405–414.
20. Афанасьев, С. Г. Нерезектабельные опухоли печени (обзор литературы) [Текст] / С. Г. Афанасьев, С. А. Тузиков // Си
бирский онкологический журнал. – 2006. – № 1. – С. 49–54.
21. Современные подходы к хирургическому лечению больных колоректальным раком с метастазами в печени [Текст] / А.
Ю. Добродеев, Д. Н. Костромицкий, С. Г. Афанасьев [и др.] // Анналы хирургической гепатологии. – 2022. – Т. 27, № 1.
– С. 80–86.
22. Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a
single institution [Text] / M. G. House, H. Ito, M. Gönen [et al.] // J Am Coll Surg. – 2010. – Vol. 210, N 5. – P. 744–752.
23. Simultaneous colorectal and parenchymal-sparing liver resection for advanced colorectal carcinoma with synchronous liver
metastases: Between conventional and mini-invasive approaches [Text] / E. De Raffele, M. Mirarchi, D. Cuicchi [et al.] // World
J Gastroenterol. – 2020. – Vol. 26, N 42. – P. 6529–6555.
24. Прогнозирование результатов комбинированного лечения пациентов с синхронными метастазами колоректального рака
[Текст] / С. В. Козлов, О. И. Каганов, А. А. Морятов [и др.] // Наука и инновации в медицине. – 2019. – Т. 4, № 3. – С. 60–
64.
25. Тактика «сначала печень» при лечении пациентов с синхронными метастазами рака прямой кишки в печени [Текст] / В.
А. Алиев, З. А. Дудаев, З. З. Мамедли [и др.] // Тазовая хирургия и онкология. – 2020. – Т. 10, № 1. – С. 50–55.
26. Неоадъювантная лучевая терапия в стратегии лечения рака прямой кишки с синхронным метастатическим поражением
печени. Обзор литературы [Текст] / Т. П. Почуев, А. А. Невольских, Л. О. Петров [и др.] // Сибирский онкологический
журнал. – 2021. – Т. 20, № 5. – С. 123–137.
27. Ihnát, P. Treatment strategies for colorectal carcinoma with synchronous liver metastases: Which way to go? [Text] / P. Ihnát, P.
Vávra, P. Zonča // World J Gastroenterol. – 2015. – Vol. 21, N 22. – P. 7014–7021.
28. Reddy S. K. Synchronous colorectal liver metastases: is it time to reconsider traditional paradigms of management? [Text] / S.
K. Reddy, A. S. Barbas, B. M. Clary // Ann Surg Oncol. – 2009. – Vol. 16, N 9. – P. 2395–2410.
29. Role of a liver-first approach for synchronous colorectal liver metastases [Text] / K. Wang, W. Liu, X. L. Yan, B. C. Xing //
World J Gastroenterol. – 2016. – Vol. 22, N 6. – P. 2126–2132.
30. Метастатический колоректальный рак. Эволюция лечебных подходов: взгляд хирурга-онколога [Текст] / В. А. Алиев, З.
З. Мамедли, Ю. А. Барсуков [и др.] // Тазовая хирургия и онкология. – 2021. – Т. 11, № 1. – С. 42–59.
31. Hopt, U. T. Timing of resection in patients with colorectal carcinoma and synchronous liver metastases [Text] / U. T. Hopt, O.
Drognitz, H. Neeff // Zentralbl Chir. – 2009. – Vol. 134, N 5. – P. 425–429.
32. Хирургическая тактика в лечении больных колоректальным раком с синхронными метастазами в печень [Текст] / Ю. И.
Патютко, Е. С. Чучуев, Д. В. Подлужный [и др.] // Онкологическая проктология. – 2013. – № 3. – С. 13–19.
33. The influence of steatosis on the short- and long-term results of resection of liver metastases from colorectal carcinoma [Text] /
E. Ramos, J. Torras, L. Lladó [et al.] // HPB (Oxford). – 2016. – Vol. 18, N 4. – P. 389–396.
34. “Liver-first” approach for synchronous colorectal liver metastases: is this a justifiable approach? [Text] / A. De Rosa, D. Gomez,
A. Brooks, I. C. Cameron // J Hepatobiliary Pancreat Sci. – 2013. – Vol. 20, N 3. – P. 263–270.
35. A survival analysis of the liver-first reversed management of advanced simultaneous colorectal liver metastases: a LiverMetSur
vey-based study [Text] / A. Andres, C. Toso, R. Adam [et al.] // Ann Surg. – 2012. – Vol. 256, N 5. – P. 772–778.
36. Timing of hepatectomy for resectable synchronous colorectal liver metastases: for whom simultaneous resection is more suit
able--a meta-analysis [Text] / Q. Feng, Y. Wei, D. Zhu [et al.] // PLoS One. – 2014. – Vol. 9, N 8:e104348.
37. Thirty-day morbidity after simultaneous resection of colorectal cancer and colorectal liver metastasis: american college of sur
geons NSQIP analysis [Text] / R. A. Snyder, S. Hao, W. Irish [et al.] // J Am Coll Surg. – 2020. – Vol. 230, N 4. – P. 617–627.e9.
38. Trends and outcomes of synchronous resection of colorectal metastasis in the modern era-analysis of targeted hepatic NSQIP
database [Text] / T. J. Jones, A. E. Murphy, A. Tameron [et al.] // J Surg Res. – 2019. – Vol. 238. – P. 35–40.
39. Adjuvant chemotherapy afterresection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative
study between h epatic arterialinfusion of oxaliplatin and modern systemic chemotherapy [Text] / D. Goéré, L. Benhaim, S. Bon
net [et al.] // Ann Surg. – 2013. – Vol. 257, N 1. – P. 114–120.
40. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS) [Text] / N.
N. Rahbari, O. J. Garden, R. Padbury [et al.] // Surgery. – 2011. – Vol. 149, N 5. – P. 713–724.
41. Simultaneous resection of colorectal cancer with synchronous liver metastases: a practice survey [Text] / S. Griffiths, J. Bogacz,
M. Simunovic [et al.] // HPB (Oxford). – 2020. – Vol. 22, N 5. – P. 728–734 42. Management of synchronous colorectal cancer liver metastases: a multidisciplinary international consensus [Text] / R. Adam, A.
de Gramont, J. Figueras [et al.] // Cancer Treat Rev. – 2015. – Vol. 41, N 9. – P. 729–741.
43. Imai, K. How to increase the resectability of initially unresectable colorectal liver metastases: A surgical perspective [Text] / K.
Imai, R. Adam, H. Baba // Ann Gastroenterol Surg. – 2019. – Vol. 3, N 5. – P. 476–486.
44. Parenchymal-sparing Hepatectomy as the New Doctrine in the Treatment of Liver-metastatic Colorectal Disease: Beyond On
cological Outcomes [Text] / D. Moris, D. Dimitroulis, S. Vernadakis [et al.] // Anticancer Res. – 2017. – Vol. 37, N 1. – P. 9–14.
45. Bolton, J. S. Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma [Text] / J. S. Bolton, G.
M. Fuhrman // Ann Surg. ‒ 2000. – Vol. 231, N 5. – P. 743–751.
46. Simultaneous versus staged liver resection of synchronous liver metastases from colorectal cancer [Text] / A. Thelen, S. Jonas,
C. Benckert [et al.] // Int J Colorectal Dis. – 2007. – Vol. 22, N 10. – P. 1269–1276.
47. Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases [Text] / K. Tanaka,
H. Shimada, K. Matsuo [et al.] // Surgery. – 2004. – Vol. 136, N 3. – P. 650–659.
48. Safety of simultaneous colon and liver resection for colorectal liver metastases [Text] / M. Stojanović, G. Stanojević, M.
Radojković [et al.] // Vonosanit Pregl. – 2008. – Vol. 65, N 2. – P. 153–157.
49. Simultaneous resection of colorectal primary tumour and synchronous liver metastases [Text] / J. C. Weber, P. Bachellier, E. Ous
soultzoglou, D. Jaeck // Br J Surg. – 2003. – Vol. 90, N 8. – P. 956–962.
50. Strategies for the treatment of synchronous liver metastasis [Text] / O. Turrini, F. Viret, J. Guiramand [et al.] // Eur J Surg Oncol.
– 2007. – Vol. 33, N 6. – P. 735–740.
51. Патютко, Ю. И. Комбинированное лечение больных колоректальным раком с метастатическим поражением печени [Тек
ст] / Ю. И. Патютко, И. В. Сагайдак, А. В. Поляков // РМЖ. – 2009. – Т. 17, № 13. – С. 853–861.
52. Comparison of simultaneous or delayed liver surgery for limited synchronous colorectal metastases [Text] / R. J. de Haas, R.
Adam, D. A. Wicherts [et al.] // Br J Surg. – 2010. – Vol. 97, N 8. – P. 1279–1289.
53. Concurrent vs. staged colectomy and hepatectomy for primary colorectal cancer with synchronous hepatic metastases [Text] / H.
K. Chua, K. Sondenaa, G. G. Tsiotos [et al.] // Dis Colon Rectum. – 2004. – Vol. 47, N 8. – P. 1310–1316.
54. Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary
[Text] / G. Mentha, P. E. Majno, A. Andres [et al.] // Br J Surg. – 2006. – Vol. 93, N 7. – P. 872–878.
55. Primary tumor versus liver-first approach for synchronous colorectal liver metastases: An Association Francaise de Chirurgie
(AFC) multicenter-based study with propensity score analysis [Text] / F. Esposito, C. Lim, A. Sa Cunha [et al.] // World J Surg.
– 2018. – Vol. 42, N 12. – P. 4046–4053.
56. Stage IV colorectal cancer: outcomes following the liver-first approach [Text] / A. De Rosa, D. Gomez, S. Hossaini [et al.] // J
Surg Oncol. – 2013. – Vol. 108, N 7. – P. 444–449.
57. Методика «liver first» в лечении больных колоректальным раком с синхронными метастазами в печени [Текст] / Д. В.
Сидоров, М. В. Ложкин, А. А. Троицкий [и др.] // Онкология. Журнал им. П. А. Герцена. – 2020. – Т. 9, № 1. – С. 45–49.
58. Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy?
[Text] / A. Brouquet, M. M. Mortenson, J. N. Vauthey [et al.] // J Am Coll Surg. – 2010. – Vol. 210, N 6. – P. 934–941.
59. Complete response of colorectal liver metastases after chemotherapy: does it mean cure? [Text] / S. Chagnon, E. Mitry, P. Rougier,
B. Nordlinger // J Clin Oncol. – 2006. – Vol. 24, N 24. – P. 3939–3945.
60. A meta-analysis comparing simultaneous versus delayed resections in patients with synchronous colorectal liver metastases
[Text] / A. A. Slesser, C. Simillis, R. Goldin [et al.] // Surg Oncol. – 2013. – Vol. 22, N 1. – P. 36–47.
61. Waisberg, J. Liver-first approach of colorectal cancer with synchronous hepatic metastases: A reverse strategy [Text] / J. Waisberg,
I. G. Ivankovics // World J Hepatol. – 2015. – Vol. 7, N 11. – P. 1444–1449.
62. Guest, R. V.Addressing the variation in hepatic surgery for colorectal liver metastasis [Text] / R. V. Guest, K. Søreide // Hepato
biliary Surg Nutr. – 2021. – Vol. 10, N 1. – P. 103–106.
63. Grundmann, R. T. Current state of surgical treatment of liver metastases from colorectal cancer [Text] / R. T. Grundmann //
World J Gastrointest Surg. – 2011. – Vol. 3, N 12. – P. 183–196.
64. Management of patients with asymptomatic colorectal cancer and synchronous irresectable metastases [Text] / M. G. Scheer, C.
E. Sloots, G. J. van der Wilt, T. J. Ruers // Ann Oncol. – 2008. – Vol. 19, N 11. – P. 1829–1835.
65. The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus
[Text] / R. Adam, A. De Gramont, J. Figueras [et al.] // Oncologist. – 2012. – Vol. 17, N 10. – P. 1225–1239.
66. Systematic review of surgical management of synchronous colorectal liver metastases [Text] / P. M. Lykoudis, D. O’Reilly, K.
Nastos, G. Fusai // Br J Surg. – 2014. – Vol. 101, N 6. – P. 605–612.
67. The liver-first approach for synchronous colorectal liver metastasis: a 5-year single-centre experience [Text] / M. C. de Jong, R.
M. van Dam, M. Maas [et al.] // HPB (Oxford). – 2011. – Vol. 13, N 10. – P. 745–752.
68. Tsoulfas, G. Management of rectal cancer and liver metastatic disease: which comes first? [Text] / G. Tsoulfas, M. G. Pramateftakis
// Int J Surg Oncol. – 2012;2012:196908.
69. Ligation of a branch of the portal vein for carcinoma of the liver [Text] / I. Honjo, T. Suzuki, K. Ozawa [et al.] // Am J Surg. –
1975. – Vol. 130, N 3. – P. 296–302.
70. Meta-analysis of associating liver partition with portal vein ligation and portal vein occlusion for two-stage hepatectomy [Text]
/ D. Eshmuminov, D.A. Raptis, M. Linecker [et al.] // Br J Surg. – 2016. – Vol. 103, N 13. – P. 1768–1782.
71. Van Gulik, T. M.James Cantlie’s early messages for hepatic surgeons: how the concept of pre-operative portal vein occlusion
was defined [Text] / T. M. van Gulik, J. W. van den Esschert // HPB (Oxford). – 2010. – Vol. 12, N 2 – P. 81–83.
72. Portal vein embolization before liver resection: a systematic review [Text] K. P. van Lienden, J. W. van den Esschert, W. de
Graaf [et al.] // Cardiovasc Intervent Radiol. – 2013. – Vol. 36, N 1. – P. 25–34.
73. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report [Te
xt] / M. Makuuchi, B. L. Thai, K. Takayasu [et al.] // Surgery. – 1990. – Vol. 107, N 5. – P. 521–527.
74. Preoperative portal vein embolization for hepatocellular carcinoma [Text] / H. Kinoshita, K. Sakai, K. Hirohashi [et al.] // World J Surg – 1986. – Vol. 10, N 5. – P. 803–808.
75. Hernandez Dominguez, O. Stage IV Colorectal Cancer Management and Treatment [et al.] / O. Hernandez Dominguez, S. Yilmaz,
S. R. Steele // J Clin Med. – 2023. – Vol. 12, N 5. – P. 2072.
76. ALPPS Improves Resectability Compared With Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal
Liver Metastasis: Results From a Scandinavian Multicenter Randomized Controlled Trial (LIGRO Trial) [Text] / P. Sandström,
B. I. Røsok, E. Sparrelid [et al.] // Ann Surg. – 2018. – Vol. 267, N 5. – P. 833–840.
77. Colorectal liver metastases: Current management and future perspectives [Text] / J. Martin, A. Petrillo, E. C. Smyth [et al.] //
World J Clin Oncol. – 2020. – Vol. 11, N 10. – P. 761–808.
78. Liver transplantation in metastatic colorectal cancer: are we ready for it? [Text] / J. Ros, F. Salva, C. Dopazo [et al.] // Br J Can
cer. – 2023. – Vol. 128, N 10. – P. 1797–1806.
79. Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors [Text] / R. Adam, A. Laurent, D. Azoulay [et al.] //
Ann Surg. – 2000. – Vol. 232, N. 6. – С. 777–785.
80. Current strategies to induce liver remnant hypertrophy before major liver resection [Text] / C. Del Basso, M. Gaillard, P. Lainas
[et al.] // World J Hepatol. – 2021. – Vol. 13, N 11. – P. 1629–1641.
81. Chemotherapy after portal vein embolization to protect against tumor growth during liver hypertrophy before hepatectomy [Text]
/ C. Fischer, L. G. Melstrom, D. Arnaoutakis [et al.] // JAMA Surg. – 2013. – Vol. 148, N 12. – P. 1103–1108.
82. Portal vein embolization stimulates tumour growth in patients with colorectal cancer liver metastases [Text] / E. Simoneau, M.
Aljiffry, A. Salman [et al.] // HPB (Oxford). – 2012. – Vol. 14, N 7. – P. 461–468.
83. Terminal branches portal vein embolization for planed hepatectomy [Text] / S. Y. Peng, C. Y. Huang, J. T. Li [et al.] // Zhonghua
Wai Ke Za Zhi. – 2016. – Vol. 54, N 9. – P. 664–668.
84. Yokoyama, Y. Mechanisms of hepatic regeneration following portal vein embolization and partial hepatectomy: a review [Text]
/ Y. Yokoyama, M. Nagino, Y. Nimura // World J Surg. – 2007. – Vol. 31, N 2. – P. 367–374.
85. Long-term outcomes of conversion hepatectomy for initially unresectable colorectal liver metastases [Text] / Y. Maeda, T. Shi
nohara, A. Nagatsu [et al.] // Ann Surg Oncol. – 2016. – Vol. 23, Suppl 2. – S242–S248.
86. Second-line systemic therapy for metastatic colorectal cancer [Text] / S. Mocellin, Z. Baretta, I.F.M. Roque [et al.] // Cochrane
Database Syst Rev. – 2017. – Vol. 1:Cd006875.
87. Combined portal vein embolization and preoperative chemotherapy prior to liver resection for colorectal cancer metastases [Te
xt] / L. Spelt, P. Norman, L. Tornqvist [et al.] // Scand J Gastroenterol. – 2012. – Vol. 47, N 8-9. – P. 975–983.
88. Impact of neoadjuvant chemotherapy on hypertrophy of the future liver remnant after associating liver partition and portal vein
ligation for staged hepatectomy [Text] / M. Kremer, G. Manzini, B. Hristov [et al.] // J Am Coll Surg. – 2015. – Vol. 221, N 3. –
P. 717–728.e1.
89. Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant
volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach
[Text] / J. Shindoh, J. N. Vauthey, G. Zimmitti [et al.] // J Am Coll Surg – 2013. – Vol. 217, N 1. – P. 126–133.
90. Dynamic Evaluation of Liver Volume and Function in Associating Liver Partition and Portal Vein Ligation for Staged Hepate
ctomy [Text] / E. Sparrelid, E. Jonas, A. Tzortzakakis [et al.] // J Gastrointest Surg. – 2017. – Vol. 21, N 6. – P. 967–974.
91. Histologic features after surgery associating liver partition and portal vein ligation for staged hepatectomy versus those after he
patectomy with portal vein embolization [Text] / K. Matsuo, T. Murakami, D. Kawaguchi [et al.] // Surgery. – 2016. – Vol. 159,
N 5. – P. 1289–1298.
92. Imaging-Based Liver Function Tests—Past, Present and Future [Text] / D. Geisel, L. Ludemann, B. Hamm [et al.] // Rofo. –
2015. – Vol. 187, N 10. – P. 863–871.
93. ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Con
trolled Trial LIGRO [Text] / K. Hasselgren, B. I. Røsok, P. N. Larsen [et al.] // Ann Surg. – 2021. – Vol. 273, N 3. – P. 442–448.
94. Operative Results and Oncologic Outcomes of Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy
(ALPPS) Versus Two-Stage Hepatectomy (TSH) in Patients with Unresectable Colorectal Liver Metastases: A Systematic Re
view and Meta-Analysis [Text] / D. Moris, S. Ronnekleiv-Kelly, I. D. Kostaki [et al.] // World J Surg. – 2018. – Vol. 42, N 3. –
P. 806–815.
95. Liver transplantation for unresectable metastases from colon adenocarcinoma [Text] / L. A. Caicedo, D. Buitrago, L. S. Thomas
[et al.] // Case Reports in Gastroenterology. – 2016. – Vol. 10, N 3. – P. 808–813.
96. Starzl, T. E. Themes of liver transplantation [Text] / T. E. Starzl, J. J. Fung // Hepatology. – 2010. – Vol. 51, N 6. – P. 1869–1884.
97. Genetic detection of lymph node micrometastases: a selection criterion for liver transplantation in patients with liver metastases
after colorectal cancer [Text] / S. Kappel, D. Kandioler, R. Steininger [et al.] // Transplantation. – 2006. – Vol. 81, N 1. – P. 64–
70.
98. Is orthotopic liver transplantation a feasible treatment for secondary cancer of the liver? [Text] / F. Mühlbacher, I. Huk, R.
Steininger [et al.] // Transplant Proc. – 1991. – Vol. 23 (1 Pt 2). – P. 1567–1568.
99. Penn, I. Hepatic transplantation for primary and metastatic cancers of the liver [Text] / I. Penn // Surgery. – 1991. – Vol. 110, N
4. – P. 726–734.
100. Recent advances in liver transplantation for cancer: The future of transplant oncology [Text] / P. Abreu, A. Gorgen, G. Oldani [et
al.] // JHEP Rep. – 2019. – Vol. 1, N 5. – P. 377–391.
101. Cost-effectiveness of liver transplantation in patients with colorectal metastases confined to the liver [Text] / G. M. W. Bjørnelv,
S. Dueland, P. D. Line [et al.] // Br J Surg. – 2019. – Vol. 106, N 1. – P. 132–141.
102. Liver transplantation for non-resectable liver metastases from colorectal cancer [Text] / M. Hagness, A. Foss, P. D. Line [et al.]
// Ann Surg. – 2013. – Vol. 257, N 5. – P. 800–806.
103. Patterns of recurrence after liver transplantation for nonresectable liver transplantation for nonresectable liver metastases from
colorectal cancer [Text] / M. Hagness, A. Foss, T. S. Egge, S. Dueland // Ann Surg Oncol. – 2014. – Vol. 21, N 4. – P. 1323–
1329.
104. Combined hepatic resection and radio-frequency ablation for patients with cancer liver metastasis: a viable option for patients with a large number of tumors [Text] / T. Masuda, G. A. Margonis, N. Andreatos [et al.] // Anticancer Res. – 2018. – Vol. 38, N
11. – P. 6353–6360.
105. FOLFOXIRI plus bevacizumab as conversion therapy for patients with initially unresectable metastatic colorectal cancer: a sys
tematic review and pooled analysis [Text] / G. Tomasello, F. Petrelli, M. Ghidini [et al.] // JAMA Oncol. – 2017. – Vol. 3, N 7.
– e170278.
106. Liver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato-Biliary Association con
sensus guidelines [Text] / G. K. Bonney, C. A. Chew, P. Lodge [et al.] // Lancet Gastroenterol Hepatol. – 2021. – Vol. 6, N 11. –
P. 933–946.
107. Liver Transplantation for Non-Resectable Liver Metastases from Colorectal Cancer: A Systematic Review and Meta-Analysis
[Text] / R. Varley, M. Tarazi, M. Davé [et al.] // World J Surg. – 2021. – Vol. 45, N 11. – P. 3404–3413.
108. Radio-frequency-assisted liver partition with portal vein ligation (RALPP) for liver regeneration [Text] / T. M. Gall, M. H. Soder
gren, A. E. Frampton [et al. // Ann. Surg. – 2015. – Vol. 261, N 2. – e45–46.
109. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy [Text] / H. Bismuth, R.
Adam, F. Lévi [et al.] // Ann. Surg. – 1996. – Vol. 224, N 4. – P. 509–520.
1. Сибирский онкологический журнал. – 2023. – Т. 22, № 2. – С. 160–167.
2. Диагностика и лечение колоректального рака [Электронный ресурс]: Клиническое руководство / Министерство здраво
охранения Кыргызской Республики; Национальный центр онкологии МЗ КР. – Режим доступа: https://ksmi.kg/images
/files/KR _%20Kolorektal_rak.pdf.
3. Hepatic Metastasis from Colorectal Cancer [Text] / A. I. Valderrama-Treviño, B. Barrera-Mera, J. C. Ceballos-Villalva [et al.] //
Euroasian J Hepatogastroenterol. – 2017. – Vol. 7, N 2. – P. 166–175.
4. The liver-first approach to the management of colorectal cancer with synchronous hepatic metastases: a systematic review [Text]
/ S. Jegatheeswaran, J. M. Mason, H. C. Hancock, A. K. Siriwardena // JAMA Surg. – 2013. – Vol. 148, N 4. – P. 385–391.
5. Стратегия и тактика комплексного лечения больных метастатическим колоректальным раком [Текст] / А. Б. Моисеенко,
А. В. Гуляев, А. М. Карачун [Текст] // Злокачественные опухоли. – 2015. – № 2. – С. 78–84.
6. Колоректальный рак с синхронными отдаленными метастазами: обоснование циторедуктивных операций и перспективы
– взгляд хирурга [Текст] / В.А. Алиев, Ю.А. Барсуков, А.В. Николаев [и др.] // Онкологическая колопроктология. – 2012.
– № 4. – С. 15–20.
7. A uniform residual tumor (R) classification: integration of the R classification and the circumferential margin status [Text] / C.
Wittekind, C. Compton, P. Quirke [et al.] // Cancer. – 2009. – Vol. 115, N 15. – P. 3483–3488.
8. Improved survival in metastatic colorectal cancer is associatedwith adoption of hepatic resection and improved chemotherapy
[Text] / S. Kopetz, J. G. Chang, M. J. Overman [et al.] // J Clin Oncol. – 2009. – Vol. 27, N 2. – P. 3677–3683.
9. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer [Text] / E. Van Cutsem, A. Cer
vantes, R. Adam [et al.] // Ann Oncol. – 2016. – Vol. 27, N 8. – P. 1386–1422.
10. EORTC liver metastases intergroup randomized phase III study 40983: long-term survival results [Text] / B. Nordlinger, H.
Sorbye, B. Glimelius [et al.] // J Clin Oncol. – 2012, vol. 30 (Suppl.). Abstr. 3508.
11. Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique
or biologic surrogate? / E. Sadot, B. G. Koerkamp, J. N. Leal [et al.] // Ann Surg. – 2015. – Vol. 262, N 3. – P. 476–485.
12. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases [Text] / Y. Fong, J. Fortner, R. L. Sun [et al.] // Ann Surg. – 1999. – Vol. 230, N 3. – P. 309–318.
13. Патютко, Ю. И. Гемигепатэктомия в лечении больных резектабельными метастазами колоректального рака в печени с
неблагоприятным прогнозом [Текст] / Ю. И. Патютко, А. Г. Котельников, К. Г. Мамонтов [и др.] // Вопросы онкологии.
‒ 2015. – Т. 61, № 3. – С. 439–447.
14. Скипенко, О. Г. Хирургическое лечение метастазов колоректального рака в печени [Текст] / О. Г. Скипенко, Л. О. Полищук
// Хирургия. Журнал им. Н. И. Пирогова. – 2009. – № 5. – С. 15–22.
15. Калинин, Е. В. Хирургический компонент лечения метастатического колоректального рака: современное состояние про
блемы [Текст] / Е. В. Калинин, Л. О. Петров // Онкология. Журнал им. П. А. Герцена. – 2016. – Т. 5, № 6. – С. 81–87.
16. Непосредственные результаты неоадъювантной химиотерапии у больных метастатическим колоректальным раком с
изолированным поражением печени [Текст] / А. Ю. Добродеев, Д. Н. Костромицкий, А. С. Тарасова [и др.] // Сибирский
онкологический журнал. – 2022. – Т. 21, № 6. – С. 17–24.
17. Early survival and safety of ALPPS: first report of the International ALPPS Registry [Text] / E. Schadde, V. Ardiles, R. Robles-
Campos [et al.] // Ann Surg. – 2014. – Vol. 260, N 5. – P. 829–836.
18. High mortality after ALPPS for perihilar cholangiocarcinoma: case-control analysis including the first series from the international
ALPPS registry [Text] / P. B. Olthof, R. J. Coelen, J. K. Wiggers [et al.] // HPB (Oxford) ‒ 2017. – Т. 19, № 5. – С. 381–387.
19. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged
extended right hepatic resection in small-for-size settings [Text] / A. A. Schnitzbauer, S. A. Lang, H. Goessmann [et al.] // Ann
Surg. ‒ 2012. – Vol. 255, N 3. – P. 405–414.
20. Афанасьев, С. Г. Нерезектабельные опухоли печени (обзор литературы) [Текст] / С. Г. Афанасьев, С. А. Тузиков // Си
бирский онкологический журнал. – 2006. – № 1. – С. 49–54.
21. Современные подходы к хирургическому лечению больных колоректальным раком с метастазами в печени [Текст] / А.
Ю. Добродеев, Д. Н. Костромицкий, С. Г. Афанасьев [и др.] // Анналы хирургической гепатологии. – 2022. – Т. 27, № 1.
– С. 80–86.
22. Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a
single institution [Text] / M. G. House, H. Ito, M. Gönen [et al.] // J Am Coll Surg. – 2010. – Vol. 210, N 5. – P. 744–752.
23. Simultaneous colorectal and parenchymal-sparing liver resection for advanced colorectal carcinoma with synchronous liver
metastases: Between conventional and mini-invasive approaches [Text] / E. De Raffele, M. Mirarchi, D. Cuicchi [et al.] // World
J Gastroenterol. – 2020. – Vol. 26, N 42. – P. 6529–6555.
24. Прогнозирование результатов комбинированного лечения пациентов с синхронными метастазами колоректального рака
[Текст] / С. В. Козлов, О. И. Каганов, А. А. Морятов [и др.] // Наука и инновации в медицине. – 2019. – Т. 4, № 3. – С. 60–
64.
25. Тактика «сначала печень» при лечении пациентов с синхронными метастазами рака прямой кишки в печени [Текст] / В.
А. Алиев, З. А. Дудаев, З. З. Мамедли [и др.] // Тазовая хирургия и онкология. – 2020. – Т. 10, № 1. – С. 50–55.
26. Неоадъювантная лучевая терапия в стратегии лечения рака прямой кишки с синхронным метастатическим поражением
печени. Обзор литературы [Текст] / Т. П. Почуев, А. А. Невольских, Л. О. Петров [и др.] // Сибирский онкологический
журнал. – 2021. – Т. 20, № 5. – С. 123–137.
27. Ihnát, P. Treatment strategies for colorectal carcinoma with synchronous liver metastases: Which way to go? [Text] / P. Ihnát, P.
Vávra, P. Zonča // World J Gastroenterol. – 2015. – Vol. 21, N 22. – P. 7014–7021.
28. Reddy S. K. Synchronous colorectal liver metastases: is it time to reconsider traditional paradigms of management? [Text] / S.
K. Reddy, A. S. Barbas, B. M. Clary // Ann Surg Oncol. – 2009. – Vol. 16, N 9. – P. 2395–2410.
29. Role of a liver-first approach for synchronous colorectal liver metastases [Text] / K. Wang, W. Liu, X. L. Yan, B. C. Xing //
World J Gastroenterol. – 2016. – Vol. 22, N 6. – P. 2126–2132.
30. Метастатический колоректальный рак. Эволюция лечебных подходов: взгляд хирурга-онколога [Текст] / В. А. Алиев, З.
З. Мамедли, Ю. А. Барсуков [и др.] // Тазовая хирургия и онкология. – 2021. – Т. 11, № 1. – С. 42–59.
31. Hopt, U. T. Timing of resection in patients with colorectal carcinoma and synchronous liver metastases [Text] / U. T. Hopt, O.
Drognitz, H. Neeff // Zentralbl Chir. – 2009. – Vol. 134, N 5. – P. 425–429.
32. Хирургическая тактика в лечении больных колоректальным раком с синхронными метастазами в печень [Текст] / Ю. И.
Патютко, Е. С. Чучуев, Д. В. Подлужный [и др.] // Онкологическая проктология. – 2013. – № 3. – С. 13–19.
33. The influence of steatosis on the short- and long-term results of resection of liver metastases from colorectal carcinoma [Text] /
E. Ramos, J. Torras, L. Lladó [et al.] // HPB (Oxford). – 2016. – Vol. 18, N 4. – P. 389–396.
34. “Liver-first” approach for synchronous colorectal liver metastases: is this a justifiable approach? [Text] / A. De Rosa, D. Gomez,
A. Brooks, I. C. Cameron // J Hepatobiliary Pancreat Sci. – 2013. – Vol. 20, N 3. – P. 263–270.
35. A survival analysis of the liver-first reversed management of advanced simultaneous colorectal liver metastases: a LiverMetSur
vey-based study [Text] / A. Andres, C. Toso, R. Adam [et al.] // Ann Surg. – 2012. – Vol. 256, N 5. – P. 772–778.
36. Timing of hepatectomy for resectable synchronous colorectal liver metastases: for whom simultaneous resection is more suit
able--a meta-analysis [Text] / Q. Feng, Y. Wei, D. Zhu [et al.] // PLoS One. – 2014. – Vol. 9, N 8:e104348.
37. Thirty-day morbidity after simultaneous resection of colorectal cancer and colorectal liver metastasis: american college of sur
geons NSQIP analysis [Text] / R. A. Snyder, S. Hao, W. Irish [et al.] // J Am Coll Surg. – 2020. – Vol. 230, N 4. – P. 617–627.e9.
38. Trends and outcomes of synchronous resection of colorectal metastasis in the modern era-analysis of targeted hepatic NSQIP
database [Text] / T. J. Jones, A. E. Murphy, A. Tameron [et al.] // J Surg Res. – 2019. – Vol. 238. – P. 35–40.
39. Adjuvant chemotherapy afterresection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative
study between h epatic arterialinfusion of oxaliplatin and modern systemic chemotherapy [Text] / D. Goéré, L. Benhaim, S. Bon
net [et al.] // Ann Surg. – 2013. – Vol. 257, N 1. – P. 114–120.
40. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS) [Text] / N.
N. Rahbari, O. J. Garden, R. Padbury [et al.] // Surgery. – 2011. – Vol. 149, N 5. – P. 713–724.
41. Simultaneous resection of colorectal cancer with synchronous liver metastases: a practice survey [Text] / S. Griffiths, J. Bogacz,
M. Simunovic [et al.] // HPB (Oxford). – 2020. – Vol. 22, N 5. – P. 728–734 42. Management of synchronous colorectal cancer liver metastases: a multidisciplinary international consensus [Text] / R. Adam, A.
de Gramont, J. Figueras [et al.] // Cancer Treat Rev. – 2015. – Vol. 41, N 9. – P. 729–741.
43. Imai, K. How to increase the resectability of initially unresectable colorectal liver metastases: A surgical perspective [Text] / K.
Imai, R. Adam, H. Baba // Ann Gastroenterol Surg. – 2019. – Vol. 3, N 5. – P. 476–486.
44. Parenchymal-sparing Hepatectomy as the New Doctrine in the Treatment of Liver-metastatic Colorectal Disease: Beyond On
cological Outcomes [Text] / D. Moris, D. Dimitroulis, S. Vernadakis [et al.] // Anticancer Res. – 2017. – Vol. 37, N 1. – P. 9–14.
45. Bolton, J. S. Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma [Text] / J. S. Bolton, G.
M. Fuhrman // Ann Surg. ‒ 2000. – Vol. 231, N 5. – P. 743–751.
46. Simultaneous versus staged liver resection of synchronous liver metastases from colorectal cancer [Text] / A. Thelen, S. Jonas,
C. Benckert [et al.] // Int J Colorectal Dis. – 2007. – Vol. 22, N 10. – P. 1269–1276.
47. Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases [Text] / K. Tanaka,
H. Shimada, K. Matsuo [et al.] // Surgery. – 2004. – Vol. 136, N 3. – P. 650–659.
48. Safety of simultaneous colon and liver resection for colorectal liver metastases [Text] / M. Stojanović, G. Stanojević, M.
Radojković [et al.] // Vonosanit Pregl. – 2008. – Vol. 65, N 2. – P. 153–157.
49. Simultaneous resection of colorectal primary tumour and synchronous liver metastases [Text] / J. C. Weber, P. Bachellier, E. Ous
soultzoglou, D. Jaeck // Br J Surg. – 2003. – Vol. 90, N 8. – P. 956–962.
50. Strategies for the treatment of synchronous liver metastasis [Text] / O. Turrini, F. Viret, J. Guiramand [et al.] // Eur J Surg Oncol.
– 2007. – Vol. 33, N 6. – P. 735–740.
51. Патютко, Ю. И. Комбинированное лечение больных колоректальным раком с метастатическим поражением печени [Тек
ст] / Ю. И. Патютко, И. В. Сагайдак, А. В. Поляков // РМЖ. – 2009. – Т. 17, № 13. – С. 853–861.
52. Comparison of simultaneous or delayed liver surgery for limited synchronous colorectal metastases [Text] / R. J. de Haas, R.
Adam, D. A. Wicherts [et al.] // Br J Surg. – 2010. – Vol. 97, N 8. – P. 1279–1289.
53. Concurrent vs. staged colectomy and hepatectomy for primary colorectal cancer with synchronous hepatic metastases [Text] / H.
K. Chua, K. Sondenaa, G. G. Tsiotos [et al.] // Dis Colon Rectum. – 2004. – Vol. 47, N 8. – P. 1310–1316.
54. Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary
[Text] / G. Mentha, P. E. Majno, A. Andres [et al.] // Br J Surg. – 2006. – Vol. 93, N 7. – P. 872–878.
55. Primary tumor versus liver-first approach for synchronous colorectal liver metastases: An Association Francaise de Chirurgie
(AFC) multicenter-based study with propensity score analysis [Text] / F. Esposito, C. Lim, A. Sa Cunha [et al.] // World J Surg.
– 2018. – Vol. 42, N 12. – P. 4046–4053.
56. Stage IV colorectal cancer: outcomes following the liver-first approach [Text] / A. De Rosa, D. Gomez, S. Hossaini [et al.] // J
Surg Oncol. – 2013. – Vol. 108, N 7. – P. 444–449.
57. Методика «liver first» в лечении больных колоректальным раком с синхронными метастазами в печени [Текст] / Д. В.
Сидоров, М. В. Ложкин, А. А. Троицкий [и др.] // Онкология. Журнал им. П. А. Герцена. – 2020. – Т. 9, № 1. – С. 45–49.
58. Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy?
[Text] / A. Brouquet, M. M. Mortenson, J. N. Vauthey [et al.] // J Am Coll Surg. – 2010. – Vol. 210, N 6. – P. 934–941.
59. Complete response of colorectal liver metastases after chemotherapy: does it mean cure? [Text] / S. Chagnon, E. Mitry, P. Rougier,
B. Nordlinger // J Clin Oncol. – 2006. – Vol. 24, N 24. – P. 3939–3945.
60. A meta-analysis comparing simultaneous versus delayed resections in patients with synchronous colorectal liver metastases
[Text] / A. A. Slesser, C. Simillis, R. Goldin [et al.] // Surg Oncol. – 2013. – Vol. 22, N 1. – P. 36–47.
61. Waisberg, J. Liver-first approach of colorectal cancer with synchronous hepatic metastases: A reverse strategy [Text] / J. Waisberg,
I. G. Ivankovics // World J Hepatol. – 2015. – Vol. 7, N 11. – P. 1444–1449.
62. Guest, R. V.Addressing the variation in hepatic surgery for colorectal liver metastasis [Text] / R. V. Guest, K. Søreide // Hepato
biliary Surg Nutr. – 2021. – Vol. 10, N 1. – P. 103–106.
63. Grundmann, R. T. Current state of surgical treatment of liver metastases from colorectal cancer [Text] / R. T. Grundmann //
World J Gastrointest Surg. – 2011. – Vol. 3, N 12. – P. 183–196.
64. Management of patients with asymptomatic colorectal cancer and synchronous irresectable metastases [Text] / M. G. Scheer, C.
E. Sloots, G. J. van der Wilt, T. J. Ruers // Ann Oncol. – 2008. – Vol. 19, N 11. – P. 1829–1835.
65. The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus
[Text] / R. Adam, A. De Gramont, J. Figueras [et al.] // Oncologist. – 2012. – Vol. 17, N 10. – P. 1225–1239.
66. Systematic review of surgical management of synchronous colorectal liver metastases [Text] / P. M. Lykoudis, D. O’Reilly, K.
Nastos, G. Fusai // Br J Surg. – 2014. – Vol. 101, N 6. – P. 605–612.
67. The liver-first approach for synchronous colorectal liver metastasis: a 5-year single-centre experience [Text] / M. C. de Jong, R.
M. van Dam, M. Maas [et al.] // HPB (Oxford). – 2011. – Vol. 13, N 10. – P. 745–752.
68. Tsoulfas, G. Management of rectal cancer and liver metastatic disease: which comes first? [Text] / G. Tsoulfas, M. G. Pramateftakis
// Int J Surg Oncol. – 2012;2012:196908.
69. Ligation of a branch of the portal vein for carcinoma of the liver [Text] / I. Honjo, T. Suzuki, K. Ozawa [et al.] // Am J Surg. –
1975. – Vol. 130, N 3. – P. 296–302.
70. Meta-analysis of associating liver partition with portal vein ligation and portal vein occlusion for two-stage hepatectomy [Text]
/ D. Eshmuminov, D.A. Raptis, M. Linecker [et al.] // Br J Surg. – 2016. – Vol. 103, N 13. – P. 1768–1782.
71. Van Gulik, T. M.James Cantlie’s early messages for hepatic surgeons: how the concept of pre-operative portal vein occlusion
was defined [Text] / T. M. van Gulik, J. W. van den Esschert // HPB (Oxford). – 2010. – Vol. 12, N 2 – P. 81–83.
72. Portal vein embolization before liver resection: a systematic review [Text] K. P. van Lienden, J. W. van den Esschert, W. de
Graaf [et al.] // Cardiovasc Intervent Radiol. – 2013. – Vol. 36, N 1. – P. 25–34.
73. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report [Te
xt] / M. Makuuchi, B. L. Thai, K. Takayasu [et al.] // Surgery. – 1990. – Vol. 107, N 5. – P. 521–527.
74. Preoperative portal vein embolization for hepatocellular carcinoma [Text] / H. Kinoshita, K. Sakai, K. Hirohashi [et al.] // World J Surg – 1986. – Vol. 10, N 5. – P. 803–808.
75. Hernandez Dominguez, O. Stage IV Colorectal Cancer Management and Treatment [et al.] / O. Hernandez Dominguez, S. Yilmaz,
S. R. Steele // J Clin Med. – 2023. – Vol. 12, N 5. – P. 2072.
76. ALPPS Improves Resectability Compared With Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal
Liver Metastasis: Results From a Scandinavian Multicenter Randomized Controlled Trial (LIGRO Trial) [Text] / P. Sandström,
B. I. Røsok, E. Sparrelid [et al.] // Ann Surg. – 2018. – Vol. 267, N 5. – P. 833–840.
77. Colorectal liver metastases: Current management and future perspectives [Text] / J. Martin, A. Petrillo, E. C. Smyth [et al.] //
World J Clin Oncol. – 2020. – Vol. 11, N 10. – P. 761–808.
78. Liver transplantation in metastatic colorectal cancer: are we ready for it? [Text] / J. Ros, F. Salva, C. Dopazo [et al.] // Br J Can
cer. – 2023. – Vol. 128, N 10. – P. 1797–1806.
79. Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors [Text] / R. Adam, A. Laurent, D. Azoulay [et al.] //
Ann Surg. – 2000. – Vol. 232, N. 6. – С. 777–785.
80. Current strategies to induce liver remnant hypertrophy before major liver resection [Text] / C. Del Basso, M. Gaillard, P. Lainas
[et al.] // World J Hepatol. – 2021. – Vol. 13, N 11. – P. 1629–1641.
81. Chemotherapy after portal vein embolization to protect against tumor growth during liver hypertrophy before hepatectomy [Text]
/ C. Fischer, L. G. Melstrom, D. Arnaoutakis [et al.] // JAMA Surg. – 2013. – Vol. 148, N 12. – P. 1103–1108.
82. Portal vein embolization stimulates tumour growth in patients with colorectal cancer liver metastases [Text] / E. Simoneau, M.
Aljiffry, A. Salman [et al.] // HPB (Oxford). – 2012. – Vol. 14, N 7. – P. 461–468.
83. Terminal branches portal vein embolization for planed hepatectomy [Text] / S. Y. Peng, C. Y. Huang, J. T. Li [et al.] // Zhonghua
Wai Ke Za Zhi. – 2016. – Vol. 54, N 9. – P. 664–668.
84. Yokoyama, Y. Mechanisms of hepatic regeneration following portal vein embolization and partial hepatectomy: a review [Text]
/ Y. Yokoyama, M. Nagino, Y. Nimura // World J Surg. – 2007. – Vol. 31, N 2. – P. 367–374.
85. Long-term outcomes of conversion hepatectomy for initially unresectable colorectal liver metastases [Text] / Y. Maeda, T. Shi
nohara, A. Nagatsu [et al.] // Ann Surg Oncol. – 2016. – Vol. 23, Suppl 2. – S242–S248.
86. Second-line systemic therapy for metastatic colorectal cancer [Text] / S. Mocellin, Z. Baretta, I.F.M. Roque [et al.] // Cochrane
Database Syst Rev. – 2017. – Vol. 1:Cd006875.
87. Combined portal vein embolization and preoperative chemotherapy prior to liver resection for colorectal cancer metastases [Te
xt] / L. Spelt, P. Norman, L. Tornqvist [et al.] // Scand J Gastroenterol. – 2012. – Vol. 47, N 8-9. – P. 975–983.
88. Impact of neoadjuvant chemotherapy on hypertrophy of the future liver remnant after associating liver partition and portal vein
ligation for staged hepatectomy [Text] / M. Kremer, G. Manzini, B. Hristov [et al.] // J Am Coll Surg. – 2015. – Vol. 221, N 3. –
P. 717–728.e1.
89. Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant
volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach
[Text] / J. Shindoh, J. N. Vauthey, G. Zimmitti [et al.] // J Am Coll Surg – 2013. – Vol. 217, N 1. – P. 126–133.
90. Dynamic Evaluation of Liver Volume and Function in Associating Liver Partition and Portal Vein Ligation for Staged Hepate
ctomy [Text] / E. Sparrelid, E. Jonas, A. Tzortzakakis [et al.] // J Gastrointest Surg. – 2017. – Vol. 21, N 6. – P. 967–974.
91. Histologic features after surgery associating liver partition and portal vein ligation for staged hepatectomy versus those after he
patectomy with portal vein embolization [Text] / K. Matsuo, T. Murakami, D. Kawaguchi [et al.] // Surgery. – 2016. – Vol. 159,
N 5. – P. 1289–1298.
92. Imaging-Based Liver Function Tests—Past, Present and Future [Text] / D. Geisel, L. Ludemann, B. Hamm [et al.] // Rofo. –
2015. – Vol. 187, N 10. – P. 863–871.
93. ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Con
trolled Trial LIGRO [Text] / K. Hasselgren, B. I. Røsok, P. N. Larsen [et al.] // Ann Surg. – 2021. – Vol. 273, N 3. – P. 442–448.
94. Operative Results and Oncologic Outcomes of Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy
(ALPPS) Versus Two-Stage Hepatectomy (TSH) in Patients with Unresectable Colorectal Liver Metastases: A Systematic Re
view and Meta-Analysis [Text] / D. Moris, S. Ronnekleiv-Kelly, I. D. Kostaki [et al.] // World J Surg. – 2018. – Vol. 42, N 3. –
P. 806–815.
95. Liver transplantation for unresectable metastases from colon adenocarcinoma [Text] / L. A. Caicedo, D. Buitrago, L. S. Thomas
[et al.] // Case Reports in Gastroenterology. – 2016. – Vol. 10, N 3. – P. 808–813.
96. Starzl, T. E. Themes of liver transplantation [Text] / T. E. Starzl, J. J. Fung // Hepatology. – 2010. – Vol. 51, N 6. – P. 1869–1884.
97. Genetic detection of lymph node micrometastases: a selection criterion for liver transplantation in patients with liver metastases
after colorectal cancer [Text] / S. Kappel, D. Kandioler, R. Steininger [et al.] // Transplantation. – 2006. – Vol. 81, N 1. – P. 64–
70.
98. Is orthotopic liver transplantation a feasible treatment for secondary cancer of the liver? [Text] / F. Mühlbacher, I. Huk, R.
Steininger [et al.] // Transplant Proc. – 1991. – Vol. 23 (1 Pt 2). – P. 1567–1568.
99. Penn, I. Hepatic transplantation for primary and metastatic cancers of the liver [Text] / I. Penn // Surgery. – 1991. – Vol. 110, N
4. – P. 726–734.
100. Recent advances in liver transplantation for cancer: The future of transplant oncology [Text] / P. Abreu, A. Gorgen, G. Oldani [et
al.] // JHEP Rep. – 2019. – Vol. 1, N 5. – P. 377–391.
101. Cost-effectiveness of liver transplantation in patients with colorectal metastases confined to the liver [Text] / G. M. W. Bjørnelv,
S. Dueland, P. D. Line [et al.] // Br J Surg. – 2019. – Vol. 106, N 1. – P. 132–141.
102. Liver transplantation for non-resectable liver metastases from colorectal cancer [Text] / M. Hagness, A. Foss, P. D. Line [et al.]
// Ann Surg. – 2013. – Vol. 257, N 5. – P. 800–806.
103. Patterns of recurrence after liver transplantation for nonresectable liver transplantation for nonresectable liver metastases from
colorectal cancer [Text] / M. Hagness, A. Foss, T. S. Egge, S. Dueland // Ann Surg Oncol. – 2014. – Vol. 21, N 4. – P. 1323–
1329.
104. Combined hepatic resection and radio-frequency ablation for patients with cancer liver metastasis: a viable option for patients with a large number of tumors [Text] / T. Masuda, G. A. Margonis, N. Andreatos [et al.] // Anticancer Res. – 2018. – Vol. 38, N
11. – P. 6353–6360.
105. FOLFOXIRI plus bevacizumab as conversion therapy for patients with initially unresectable metastatic colorectal cancer: a sys
tematic review and pooled analysis [Text] / G. Tomasello, F. Petrelli, M. Ghidini [et al.] // JAMA Oncol. – 2017. – Vol. 3, N 7.
– e170278.
106. Liver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato-Biliary Association con
sensus guidelines [Text] / G. K. Bonney, C. A. Chew, P. Lodge [et al.] // Lancet Gastroenterol Hepatol. – 2021. – Vol. 6, N 11. –
P. 933–946.
107. Liver Transplantation for Non-Resectable Liver Metastases from Colorectal Cancer: A Systematic Review and Meta-Analysis
[Text] / R. Varley, M. Tarazi, M. Davé [et al.] // World J Surg. – 2021. – Vol. 45, N 11. – P. 3404–3413.
108. Radio-frequency-assisted liver partition with portal vein ligation (RALPP) for liver regeneration [Text] / T. M. Gall, M. H. Soder
gren, A. E. Frampton [et al. // Ann. Surg. – 2015. – Vol. 261, N 2. – e45–46.
109. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy [Text] / H. Bismuth, R.
Adam, F. Lévi [et al.] // Ann. Surg. – 1996. – Vol. 224, N 4. – P. 509–520.
1. Сибирский онкологический журнал. – 2023. – Т. 22, № 2. – С. 160–167.
2. Диагностика и лечение колоректального рака [Электронный ресурс]: Клиническое руководство / Министерство здраво
охранения Кыргызской Республики; Национальный центр онкологии МЗ КР. – Режим доступа: https://ksmi.kg/images
/files/KR _%20Kolorektal_rak.pdf.
3. Hepatic Metastasis from Colorectal Cancer [Text] / A. I. Valderrama-Treviño, B. Barrera-Mera, J. C. Ceballos-Villalva [et al.] //
Euroasian J Hepatogastroenterol. – 2017. – Vol. 7, N 2. – P. 166–175.
4. The liver-first approach to the management of colorectal cancer with synchronous hepatic metastases: a systematic review [Text]
/ S. Jegatheeswaran, J. M. Mason, H. C. Hancock, A. K. Siriwardena // JAMA Surg. – 2013. – Vol. 148, N 4. – P. 385–391.
5. Стратегия и тактика комплексного лечения больных метастатическим колоректальным раком [Текст] / А. Б. Моисеенко,
А. В. Гуляев, А. М. Карачун [Текст] // Злокачественные опухоли. – 2015. – № 2. – С. 78–84.
6. Колоректальный рак с синхронными отдаленными метастазами: обоснование циторедуктивных операций и перспективы
– взгляд хирурга [Текст] / В.А. Алиев, Ю.А. Барсуков, А.В. Николаев [и др.] // Онкологическая колопроктология. – 2012.
– № 4. – С. 15–20.
7. A uniform residual tumor (R) classification: integration of the R classification and the circumferential margin status [Text] / C.
Wittekind, C. Compton, P. Quirke [et al.] // Cancer. – 2009. – Vol. 115, N 15. – P. 3483–3488.
8. Improved survival in metastatic colorectal cancer is associatedwith adoption of hepatic resection and improved chemotherapy
[Text] / S. Kopetz, J. G. Chang, M. J. Overman [et al.] // J Clin Oncol. – 2009. – Vol. 27, N 2. – P. 3677–3683.
9. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer [Text] / E. Van Cutsem, A. Cer
vantes, R. Adam [et al.] // Ann Oncol. – 2016. – Vol. 27, N 8. – P. 1386–1422.
10. EORTC liver metastases intergroup randomized phase III study 40983: long-term survival results [Text] / B. Nordlinger, H.
Sorbye, B. Glimelius [et al.] // J Clin Oncol. – 2012, vol. 30 (Suppl.). Abstr. 3508.
11. Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique
or biologic surrogate? / E. Sadot, B. G. Koerkamp, J. N. Leal [et al.] // Ann Surg. – 2015. – Vol. 262, N 3. – P. 476–485.
12. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases [Text] / Y. Fong, J. Fortner, R. L. Sun [et al.] // Ann Surg. – 1999. – Vol. 230, N 3. – P. 309–318.
13. Патютко, Ю. И. Гемигепатэктомия в лечении больных резектабельными метастазами колоректального рака в печени с
неблагоприятным прогнозом [Текст] / Ю. И. Патютко, А. Г. Котельников, К. Г. Мамонтов [и др.] // Вопросы онкологии.
‒ 2015. – Т. 61, № 3. – С. 439–447.
14. Скипенко, О. Г. Хирургическое лечение метастазов колоректального рака в печени [Текст] / О. Г. Скипенко, Л. О. Полищук
// Хирургия. Журнал им. Н. И. Пирогова. – 2009. – № 5. – С. 15–22.
15. Калинин, Е. В. Хирургический компонент лечения метастатического колоректального рака: современное состояние про
блемы [Текст] / Е. В. Калинин, Л. О. Петров // Онкология. Журнал им. П. А. Герцена. – 2016. – Т. 5, № 6. – С. 81–87.
16. Непосредственные результаты неоадъювантной химиотерапии у больных метастатическим колоректальным раком с
изолированным поражением печени [Текст] / А. Ю. Добродеев, Д. Н. Костромицкий, А. С. Тарасова [и др.] // Сибирский
онкологический журнал. – 2022. – Т. 21, № 6. – С. 17–24.
17. Early survival and safety of ALPPS: first report of the International ALPPS Registry [Text] / E. Schadde, V. Ardiles, R. Robles-
Campos [et al.] // Ann Surg. – 2014. – Vol. 260, N 5. – P. 829–836.
18. High mortality after ALPPS for perihilar cholangiocarcinoma: case-control analysis including the first series from the international
ALPPS registry [Text] / P. B. Olthof, R. J. Coelen, J. K. Wiggers [et al.] // HPB (Oxford) ‒ 2017. – Т. 19, № 5. – С. 381–387.
19. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged
extended right hepatic resection in small-for-size settings [Text] / A. A. Schnitzbauer, S. A. Lang, H. Goessmann [et al.] // Ann
Surg. ‒ 2012. – Vol. 255, N 3. – P. 405–414.
20. Афанасьев, С. Г. Нерезектабельные опухоли печени (обзор литературы) [Текст] / С. Г. Афанасьев, С. А. Тузиков // Си
бирский онкологический журнал. – 2006. – № 1. – С. 49–54.
21. Современные подходы к хирургическому лечению больных колоректальным раком с метастазами в печени [Текст] / А.
Ю. Добродеев, Д. Н. Костромицкий, С. Г. Афанасьев [и др.] // Анналы хирургической гепатологии. – 2022. – Т. 27, № 1.
– С. 80–86.
22. Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a
single institution [Text] / M. G. House, H. Ito, M. Gönen [et al.] // J Am Coll Surg. – 2010. – Vol. 210, N 5. – P. 744–752.
23. Simultaneous colorectal and parenchymal-sparing liver resection for advanced colorectal carcinoma with synchronous liver
metastases: Between conventional and mini-invasive approaches [Text] / E. De Raffele, M. Mirarchi, D. Cuicchi [et al.] // World
J Gastroenterol. – 2020. – Vol. 26, N 42. – P. 6529–6555.
24. Прогнозирование результатов комбинированного лечения пациентов с синхронными метастазами колоректального рака
[Текст] / С. В. Козлов, О. И. Каганов, А. А. Морятов [и др.] // Наука и инновации в медицине. – 2019. – Т. 4, № 3. – С. 60–
64.
25. Тактика «сначала печень» при лечении пациентов с синхронными метастазами рака прямой кишки в печени [Текст] / В.
А. Алиев, З. А. Дудаев, З. З. Мамедли [и др.] // Тазовая хирургия и онкология. – 2020. – Т. 10, № 1. – С. 50–55.
26. Неоадъювантная лучевая терапия в стратегии лечения рака прямой кишки с синхронным метастатическим поражением
печени. Обзор литературы [Текст] / Т. П. Почуев, А. А. Невольских, Л. О. Петров [и др.] // Сибирский онкологический
журнал. – 2021. – Т. 20, № 5. – С. 123–137.
27. Ihnát, P. Treatment strategies for colorectal carcinoma with synchronous liver metastases: Which way to go? [Text] / P. Ihnát, P.
Vávra, P. Zonča // World J Gastroenterol. – 2015. – Vol. 21, N 22. – P. 7014–7021.
28. Reddy S. K. Synchronous colorectal liver metastases: is it time to reconsider traditional paradigms of management? [Text] / S.
K. Reddy, A. S. Barbas, B. M. Clary // Ann Surg Oncol. – 2009. – Vol. 16, N 9. – P. 2395–2410.
29. Role of a liver-first approach for synchronous colorectal liver metastases [Text] / K. Wang, W. Liu, X. L. Yan, B. C. Xing //
World J Gastroenterol. – 2016. – Vol. 22, N 6. – P. 2126–2132.
30. Метастатический колоректальный рак. Эволюция лечебных подходов: взгляд хирурга-онколога [Текст] / В. А. Алиев, З.
З. Мамедли, Ю. А. Барсуков [и др.] // Тазовая хирургия и онкология. – 2021. – Т. 11, № 1. – С. 42–59.
31. Hopt, U. T. Timing of resection in patients with colorectal carcinoma and synchronous liver metastases [Text] / U. T. Hopt, O.
Drognitz, H. Neeff // Zentralbl Chir. – 2009. – Vol. 134, N 5. – P. 425–429.
32. Хирургическая тактика в лечении больных колоректальным раком с синхронными метастазами в печень [Текст] / Ю. И.
Патютко, Е. С. Чучуев, Д. В. Подлужный [и др.] // Онкологическая проктология. – 2013. – № 3. – С. 13–19.
33. The influence of steatosis on the short- and long-term results of resection of liver metastases from colorectal carcinoma [Text] /
E. Ramos, J. Torras, L. Lladó [et al.] // HPB (Oxford). – 2016. – Vol. 18, N 4. – P. 389–396.
34. “Liver-first” approach for synchronous colorectal liver metastases: is this a justifiable approach? [Text] / A. De Rosa, D. Gomez,
A. Brooks, I. C. Cameron // J Hepatobiliary Pancreat Sci. – 2013. – Vol. 20, N 3. – P. 263–270.
35. A survival analysis of the liver-first reversed management of advanced simultaneous colorectal liver metastases: a LiverMetSur
vey-based study [Text] / A. Andres, C. Toso, R. Adam [et al.] // Ann Surg. – 2012. – Vol. 256, N 5. – P. 772–778.
36. Timing of hepatectomy for resectable synchronous colorectal liver metastases: for whom simultaneous resection is more suit
able--a meta-analysis [Text] / Q. Feng, Y. Wei, D. Zhu [et al.] // PLoS One. – 2014. – Vol. 9, N 8:e104348.
37. Thirty-day morbidity after simultaneous resection of colorectal cancer and colorectal liver metastasis: american college of sur
geons NSQIP analysis [Text] / R. A. Snyder, S. Hao, W. Irish [et al.] // J Am Coll Surg. – 2020. – Vol. 230, N 4. – P. 617–627.e9.
38. Trends and outcomes of synchronous resection of colorectal metastasis in the modern era-analysis of targeted hepatic NSQIP
database [Text] / T. J. Jones, A. E. Murphy, A. Tameron [et al.] // J Surg Res. – 2019. – Vol. 238. – P. 35–40.
39. Adjuvant chemotherapy afterresection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative
study between h epatic arterialinfusion of oxaliplatin and modern systemic chemotherapy [Text] / D. Goéré, L. Benhaim, S. Bon
net [et al.] // Ann Surg. – 2013. – Vol. 257, N 1. – P. 114–120.
40. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS) [Text] / N.
N. Rahbari, O. J. Garden, R. Padbury [et al.] // Surgery. – 2011. – Vol. 149, N 5. – P. 713–724.
41. Simultaneous resection of colorectal cancer with synchronous liver metastases: a practice survey [Text] / S. Griffiths, J. Bogacz,
M. Simunovic [et al.] // HPB (Oxford). – 2020. – Vol. 22, N 5. – P. 728–734 42. Management of synchronous colorectal cancer liver metastases: a multidisciplinary international consensus [Text] / R. Adam, A.
de Gramont, J. Figueras [et al.] // Cancer Treat Rev. – 2015. – Vol. 41, N 9. – P. 729–741.
43. Imai, K. How to increase the resectability of initially unresectable colorectal liver metastases: A surgical perspective [Text] / K.
Imai, R. Adam, H. Baba // Ann Gastroenterol Surg. – 2019. – Vol. 3, N 5. – P. 476–486.
44. Parenchymal-sparing Hepatectomy as the New Doctrine in the Treatment of Liver-metastatic Colorectal Disease: Beyond On
cological Outcomes [Text] / D. Moris, D. Dimitroulis, S. Vernadakis [et al.] // Anticancer Res. – 2017. – Vol. 37, N 1. – P. 9–14.
45. Bolton, J. S. Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma [Text] / J. S. Bolton, G.
M. Fuhrman // Ann Surg. ‒ 2000. – Vol. 231, N 5. – P. 743–751.
46. Simultaneous versus staged liver resection of synchronous liver metastases from colorectal cancer [Text] / A. Thelen, S. Jonas,
C. Benckert [et al.] // Int J Colorectal Dis. – 2007. – Vol. 22, N 10. – P. 1269–1276.
47. Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases [Text] / K. Tanaka,
H. Shimada, K. Matsuo [et al.] // Surgery. – 2004. – Vol. 136, N 3. – P. 650–659.
48. Safety of simultaneous colon and liver resection for colorectal liver metastases [Text] / M. Stojanović, G. Stanojević, M.
Radojković [et al.] // Vonosanit Pregl. – 2008. – Vol. 65, N 2. – P. 153–157.
49. Simultaneous resection of colorectal primary tumour and synchronous liver metastases [Text] / J. C. Weber, P. Bachellier, E. Ous
soultzoglou, D. Jaeck // Br J Surg. – 2003. – Vol. 90, N 8. – P. 956–962.
50. Strategies for the treatment of synchronous liver metastasis [Text] / O. Turrini, F. Viret, J. Guiramand [et al.] // Eur J Surg Oncol.
– 2007. – Vol. 33, N 6. – P. 735–740.
51. Патютко, Ю. И. Комбинированное лечение больных колоректальным раком с метастатическим поражением печени [Тек
ст] / Ю. И. Патютко, И. В. Сагайдак, А. В. Поляков // РМЖ. – 2009. – Т. 17, № 13. – С. 853–861.
52. Comparison of simultaneous or delayed liver surgery for limited synchronous colorectal metastases [Text] / R. J. de Haas, R.
Adam, D. A. Wicherts [et al.] // Br J Surg. – 2010. – Vol. 97, N 8. – P. 1279–1289.
53. Concurrent vs. staged colectomy and hepatectomy for primary colorectal cancer with synchronous hepatic metastases [Text] / H.
K. Chua, K. Sondenaa, G. G. Tsiotos [et al.] // Dis Colon Rectum. – 2004. – Vol. 47, N 8. – P. 1310–1316.
54. Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary
[Text] / G. Mentha, P. E. Majno, A. Andres [et al.] // Br J Surg. – 2006. – Vol. 93, N 7. – P. 872–878.
55. Primary tumor versus liver-first approach for synchronous colorectal liver metastases: An Association Francaise de Chirurgie
(AFC) multicenter-based study with propensity score analysis [Text] / F. Esposito, C. Lim, A. Sa Cunha [et al.] // World J Surg.
– 2018. – Vol. 42, N 12. – P. 4046–4053.
56. Stage IV colorectal cancer: outcomes following the liver-first approach [Text] / A. De Rosa, D. Gomez, S. Hossaini [et al.] // J
Surg Oncol. – 2013. – Vol. 108, N 7. – P. 444–449.
57. Методика «liver first» в лечении больных колоректальным раком с синхронными метастазами в печени [Текст] / Д. В.
Сидоров, М. В. Ложкин, А. А. Троицкий [и др.] // Онкология. Журнал им. П. А. Герцена. – 2020. – Т. 9, № 1. – С. 45–49.
58. Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy?
[Text] / A. Brouquet, M. M. Mortenson, J. N. Vauthey [et al.] // J Am Coll Surg. – 2010. – Vol. 210, N 6. – P. 934–941.
59. Complete response of colorectal liver metastases after chemotherapy: does it mean cure? [Text] / S. Chagnon, E. Mitry, P. Rougier,
B. Nordlinger // J Clin Oncol. – 2006. – Vol. 24, N 24. – P. 3939–3945.
60. A meta-analysis comparing simultaneous versus delayed resections in patients with synchronous colorectal liver metastases
[Text] / A. A. Slesser, C. Simillis, R. Goldin [et al.] // Surg Oncol. – 2013. – Vol. 22, N 1. – P. 36–47.
61. Waisberg, J. Liver-first approach of colorectal cancer with synchronous hepatic metastases: A reverse strategy [Text] / J. Waisberg,
I. G. Ivankovics // World J Hepatol. – 2015. – Vol. 7, N 11. – P. 1444–1449.
62. Guest, R. V.Addressing the variation in hepatic surgery for colorectal liver metastasis [Text] / R. V. Guest, K. Søreide // Hepato
biliary Surg Nutr. – 2021. – Vol. 10, N 1. – P. 103–106.
63. Grundmann, R. T. Current state of surgical treatment of liver metastases from colorectal cancer [Text] / R. T. Grundmann //
World J Gastrointest Surg. – 2011. – Vol. 3, N 12. – P. 183–196.
64. Management of patients with asymptomatic colorectal cancer and synchronous irresectable metastases [Text] / M. G. Scheer, C.
E. Sloots, G. J. van der Wilt, T. J. Ruers // Ann Oncol. – 2008. – Vol. 19, N 11. – P. 1829–1835.
65. The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus
[Text] / R. Adam, A. De Gramont, J. Figueras [et al.] // Oncologist. – 2012. – Vol. 17, N 10. – P. 1225–1239.
66. Systematic review of surgical management of synchronous colorectal liver metastases [Text] / P. M. Lykoudis, D. O’Reilly, K.
Nastos, G. Fusai // Br J Surg. – 2014. – Vol. 101, N 6. – P. 605–612.
67. The liver-first approach for synchronous colorectal liver metastasis: a 5-year single-centre experience [Text] / M. C. de Jong, R.
M. van Dam, M. Maas [et al.] // HPB (Oxford). – 2011. – Vol. 13, N 10. – P. 745–752.
68. Tsoulfas, G. Management of rectal cancer and liver metastatic disease: which comes first? [Text] / G. Tsoulfas, M. G. Pramateftakis
// Int J Surg Oncol. – 2012;2012:196908.
69. Ligation of a branch of the portal vein for carcinoma of the liver [Text] / I. Honjo, T. Suzuki, K. Ozawa [et al.] // Am J Surg. –
1975. – Vol. 130, N 3. – P. 296–302.
70. Meta-analysis of associating liver partition with portal vein ligation and portal vein occlusion for two-stage hepatectomy [Text]
/ D. Eshmuminov, D.A. Raptis, M. Linecker [et al.] // Br J Surg. – 2016. – Vol. 103, N 13. – P. 1768–1782.
71. Van Gulik, T. M.James Cantlie’s early messages for hepatic surgeons: how the concept of pre-operative portal vein occlusion
was defined [Text] / T. M. van Gulik, J. W. van den Esschert // HPB (Oxford). – 2010. – Vol. 12, N 2 – P. 81–83.
72. Portal vein embolization before liver resection: a systematic review [Text] K. P. van Lienden, J. W. van den Esschert, W. de
Graaf [et al.] // Cardiovasc Intervent Radiol. – 2013. – Vol. 36, N 1. – P. 25–34.
73. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report [Te
xt] / M. Makuuchi, B. L. Thai, K. Takayasu [et al.] // Surgery. – 1990. – Vol. 107, N 5. – P. 521–527.
74. Preoperative portal vein embolization for hepatocellular carcinoma [Text] / H. Kinoshita, K. Sakai, K. Hirohashi [et al.] // World J Surg – 1986. – Vol. 10, N 5. – P. 803–808.
75. Hernandez Dominguez, O. Stage IV Colorectal Cancer Management and Treatment [et al.] / O. Hernandez Dominguez, S. Yilmaz,
S. R. Steele // J Clin Med. – 2023. – Vol. 12, N 5. – P. 2072.
76. ALPPS Improves Resectability Compared With Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal
Liver Metastasis: Results From a Scandinavian Multicenter Randomized Controlled Trial (LIGRO Trial) [Text] / P. Sandström,
B. I. Røsok, E. Sparrelid [et al.] // Ann Surg. – 2018. – Vol. 267, N 5. – P. 833–840.
77. Colorectal liver metastases: Current management and future perspectives [Text] / J. Martin, A. Petrillo, E. C. Smyth [et al.] //
World J Clin Oncol. – 2020. – Vol. 11, N 10. – P. 761–808.
78. Liver transplantation in metastatic colorectal cancer: are we ready for it? [Text] / J. Ros, F. Salva, C. Dopazo [et al.] // Br J Can
cer. – 2023. – Vol. 128, N 10. – P. 1797–1806.
79. Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors [Text] / R. Adam, A. Laurent, D. Azoulay [et al.] //
Ann Surg. – 2000. – Vol. 232, N. 6. – С. 777–785.
80. Current strategies to induce liver remnant hypertrophy before major liver resection [Text] / C. Del Basso, M. Gaillard, P. Lainas
[et al.] // World J Hepatol. – 2021. – Vol. 13, N 11. – P. 1629–1641.
81. Chemotherapy after portal vein embolization to protect against tumor growth during liver hypertrophy before hepatectomy [Text]
/ C. Fischer, L. G. Melstrom, D. Arnaoutakis [et al.] // JAMA Surg. – 2013. – Vol. 148, N 12. – P. 1103–1108.
82. Portal vein embolization stimulates tumour growth in patients with colorectal cancer liver metastases [Text] / E. Simoneau, M.
Aljiffry, A. Salman [et al.] // HPB (Oxford). – 2012. – Vol. 14, N 7. – P. 461–468.
83. Terminal branches portal vein embolization for planed hepatectomy [Text] / S. Y. Peng, C. Y. Huang, J. T. Li [et al.] // Zhonghua
Wai Ke Za Zhi. – 2016. – Vol. 54, N 9. – P. 664–668.
84. Yokoyama, Y. Mechanisms of hepatic regeneration following portal vein embolization and partial hepatectomy: a review [Text]
/ Y. Yokoyama, M. Nagino, Y. Nimura // World J Surg. – 2007. – Vol. 31, N 2. – P. 367–374.
85. Long-term outcomes of conversion hepatectomy for initially unresectable colorectal liver metastases [Text] / Y. Maeda, T. Shi
nohara, A. Nagatsu [et al.] // Ann Surg Oncol. – 2016. – Vol. 23, Suppl 2. – S242–S248.
86. Second-line systemic therapy for metastatic colorectal cancer [Text] / S. Mocellin, Z. Baretta, I.F.M. Roque [et al.] // Cochrane
Database Syst Rev. – 2017. – Vol. 1:Cd006875.
87. Combined portal vein embolization and preoperative chemotherapy prior to liver resection for colorectal cancer metastases [Te
xt] / L. Spelt, P. Norman, L. Tornqvist [et al.] // Scand J Gastroenterol. – 2012. – Vol. 47, N 8-9. – P. 975–983.
88. Impact of neoadjuvant chemotherapy on hypertrophy of the future liver remnant after associating liver partition and portal vein
ligation for staged hepatectomy [Text] / M. Kremer, G. Manzini, B. Hristov [et al.] // J Am Coll Surg. – 2015. – Vol. 221, N 3. –
P. 717–728.e1.
89. Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant
volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach
[Text] / J. Shindoh, J. N. Vauthey, G. Zimmitti [et al.] // J Am Coll Surg – 2013. – Vol. 217, N 1. – P. 126–133.
90. Dynamic Evaluation of Liver Volume and Function in Associating Liver Partition and Portal Vein Ligation for Staged Hepate
ctomy [Text] / E. Sparrelid, E. Jonas, A. Tzortzakakis [et al.] // J Gastrointest Surg. – 2017. – Vol. 21, N 6. – P. 967–974.
91. Histologic features after surgery associating liver partition and portal vein ligation for staged hepatectomy versus those after he
patectomy with portal vein embolization [Text] / K. Matsuo, T. Murakami, D. Kawaguchi [et al.] // Surgery. – 2016. – Vol. 159,
N 5. – P. 1289–1298.
92. Imaging-Based Liver Function Tests—Past, Present and Future [Text] / D. Geisel, L. Ludemann, B. Hamm [et al.] // Rofo. –
2015. – Vol. 187, N 10. – P. 863–871.
93. ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Con
trolled Trial LIGRO [Text] / K. Hasselgren, B. I. Røsok, P. N. Larsen [et al.] // Ann Surg. – 2021. – Vol. 273, N 3. – P. 442–448.
94. Operative Results and Oncologic Outcomes of Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy
(ALPPS) Versus Two-Stage Hepatectomy (TSH) in Patients with Unresectable Colorectal Liver Metastases: A Systematic Re
view and Meta-Analysis [Text] / D. Moris, S. Ronnekleiv-Kelly, I. D. Kostaki [et al.] // World J Surg. – 2018. – Vol. 42, N 3. –
P. 806–815.
95. Liver transplantation for unresectable metastases from colon adenocarcinoma [Text] / L. A. Caicedo, D. Buitrago, L. S. Thomas
[et al.] // Case Reports in Gastroenterology. – 2016. – Vol. 10, N 3. – P. 808–813.
96. Starzl, T. E. Themes of liver transplantation [Text] / T. E. Starzl, J. J. Fung // Hepatology. – 2010. – Vol. 51, N 6. – P. 1869–1884.
97. Genetic detection of lymph node micrometastases: a selection criterion for liver transplantation in patients with liver metastases
after colorectal cancer [Text] / S. Kappel, D. Kandioler, R. Steininger [et al.] // Transplantation. – 2006. – Vol. 81, N 1. – P. 64–
70.
98. Is orthotopic liver transplantation a feasible treatment for secondary cancer of the liver? [Text] / F. Mühlbacher, I. Huk, R.
Steininger [et al.] // Transplant Proc. – 1991. – Vol. 23 (1 Pt 2). – P. 1567–1568.
99. Penn, I. Hepatic transplantation for primary and metastatic cancers of the liver [Text] / I. Penn // Surgery. – 1991. – Vol. 110, N
4. – P. 726–734.
100. Recent advances in liver transplantation for cancer: The future of transplant oncology [Text] / P. Abreu, A. Gorgen, G. Oldani [et
al.] // JHEP Rep. – 2019. – Vol. 1, N 5. – P. 377–391.
101. Cost-effectiveness of liver transplantation in patients with colorectal metastases confined to the liver [Text] / G. M. W. Bjørnelv,
S. Dueland, P. D. Line [et al.] // Br J Surg. – 2019. – Vol. 106, N 1. – P. 132–141.
102. Liver transplantation for non-resectable liver metastases from colorectal cancer [Text] / M. Hagness, A. Foss, P. D. Line [et al.]
// Ann Surg. – 2013. – Vol. 257, N 5. – P. 800–806.
103. Patterns of recurrence after liver transplantation for nonresectable liver transplantation for nonresectable liver metastases from
colorectal cancer [Text] / M. Hagness, A. Foss, T. S. Egge, S. Dueland // Ann Surg Oncol. – 2014. – Vol. 21, N 4. – P. 1323–
1329.
104. Combined hepatic resection and radio-frequency ablation for patients with cancer liver metastasis: a viable option for patients with a large number of tumors [Text] / T. Masuda, G. A. Margonis, N. Andreatos [et al.] // Anticancer Res. – 2018. – Vol. 38, N
11. – P. 6353–6360.
105. FOLFOXIRI plus bevacizumab as conversion therapy for patients with initially unresectable metastatic colorectal cancer: a sys
tematic review and pooled analysis [Text] / G. Tomasello, F. Petrelli, M. Ghidini [et al.] // JAMA Oncol. – 2017. – Vol. 3, N 7.
– e170278.
106. Liver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato-Biliary Association con
sensus guidelines [Text] / G. K. Bonney, C. A. Chew, P. Lodge [et al.] // Lancet Gastroenterol Hepatol. – 2021. – Vol. 6, N 11. –
P. 933–946.
107. Liver Transplantation for Non-Resectable Liver Metastases from Colorectal Cancer: A Systematic Review and Meta-Analysis
[Text] / R. Varley, M. Tarazi, M. Davé [et al.] // World J Surg. – 2021. – Vol. 45, N 11. – P. 3404–3413.
108. Radio-frequency-assisted liver partition with portal vein ligation (RALPP) for liver regeneration [Text] / T. M. Gall, M. H. Soder
gren, A. E. Frampton [et al. // Ann. Surg. – 2015. – Vol. 261, N 2. – e45–46.
109. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy [Text] / H. Bismuth, R.
Adam, F. Lévi [et al.] // Ann. Surg. – 1996. – Vol. 224, N 4. – P. 509–520.
